Amendment Five.pdf

PDF 153 KB Posted

Attached to
Interventional Agents Safety and Pharmacokinetic Services
Solicitation number
75N93024R00003
Issued by

About this file

This document is Amendment Five to Solicitation 75N93024R00003 for "Interventional Agents Safety and Pharmacokinetic Services." The amendment addresses a question regarding the submission of past performance information, clarifying that offerors may submit information on similar work as a prime or subcontractor.

The underlying solicitation is for a multiple-award IDIQ contract to provide preclinical and non-clinical development support services for promising therapeutic candidates against diseases caused by pathogens or toxins. The contract will encompass activities required for IND, NDA, and BLA filings, including product development planning, in vitro and in vivo safety and efficacy studies, ADME screening, and a kick-off meeting. Offerors may need to utilize subcontractors or partnerships to meet the full scope of work. Proposals are due May 24, 2024, and the anticipated contract start date is May 1, 2025 with a 7-year ordering period.

View the file

Other files

File Type Posted
Amendment Seven.pdf PDF
Amendment Six.pdf PDF
Amendment Four.pdf PDF
Amendment Three.pdf PDF
Amendment Two.pdf PDF
Amendment One.pdf PDF
Attachment 23 - Electronic Invoicing Instructions.pdf PDF
Attachment 19 - NIH(RC)-4.pdf PDF
Attachment 16 - Certificate of Current Cost or Pricing Data.pdf PDF
Attachment 1 - Packaging and Delivery.pdf PDF
Attachment 3 - Statement of Work.pdf PDF
Attachment 11 - Acquisition Guidance on the Voluntary Product Accessibility Template (VPAT).pdf PDF
Attachment 21 - Instructions for NIH 2706.pdf PDF
Attachment 17 - Disclosure of Lobbying Activities.pdf PDF
RFP 75N93024R00003.pdf PDF
Attachment 18 - NIH(RC)-2.pdf PDF
Attachment 7 - Additional Business Proposal Instructions.pdf PDF
Attachment 14 - Breakdown of Proposed Estimated Costs.xlsx XLSX spreadsheet
Attachment 4 - REPRESENTATIONS CERTIFICATIONS AND OTHER STATEMENTS OF OFFERORS.pdf PDF
Attachment 9 - Summary Related Activities.pdf PDF
Attachment 15 - Offerors Point-of-Contact.pdf PDF
Attachment 2 - Intent Response Form.pdf PDF
Attachment 12 - Proposal Summary and Data Record NIH2043.pdf PDF
Attachment 8 - Techical Proposal Cost Summary.pdf PDF
Attachment 5 - Additional Technical Proposal Instructions.pdf PDF
Attachment 13 - HHS Subcontracting Plan Template.pdf PDF
Attachment 20 - NIH 2706.pdf PDF
Attachment 6 - Sample Task Orders.pdf PDF
Attachment 22 - HHSAR 352.223-70 Safety and Health.pdf PDF
Attachment 10 - Contract Proposal Vertebrate Animal Section Worksheet.pdf PDF
Show all 30

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

75N93024R00003 Page 1 of 1

AMENDMENT #5

75N93024R00003

“INTERVENTIONAL AGENTS SAFETY AND PHARMACOKINETIC SERVICES”

AMENDMENT No. 5

Amendment Number: Five (5)

Amendment Issue Date: April 23, 2024

Proposal Due Date: May 24, 2024, 3:00PM EST (UNCHANGED)

Issued By:

Miranda Adams Contracting Officer Office of Acquisitions, DEA National Institute of Allergy and Infectious Diseases National Institutes of Health 5601 Fishers Lane

MSC 9821

Rockville, Maryland 20852-9821

Point of Contact:

Miranda Adams, Contracting Officer Email: miranda.adams@nih.gov.

Offerors must acknowledge receipt of the final posting of Amendment #5, on each copy of the proposal submitted. Failure to receive your acknowledgment of this Amendment may result in the rejection of your proposal.

The hour and date specified for receipt of proposals HAS NOT been extended.

PURPOSE OF SOLICITATION AMENDMENT:

The purpose of this amendment is to address questions regarding 75N93024R00003.

Question 1: Regarding the page 79, section 15, “Past Performance Information”: Is it acceptable to submit past performance information from subcontractors/partners, or must the references only be from the Prime?

Answer 1: Offerors should submit past performance information on similar work to the solicitation as a prime or as a subcontractor.

End of Amendment 5 mailto:miranda.adams@nih.gov.

File details come from the government source that posted it. Updated .